SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-142673
Filing Date
2018-04-30
Accepted
2018-04-30 15:07:03
Documents
7
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d608161ddefa14a.htm DEFA14A 42564
2 GRAPHIC g608161notacc1a.jpg GRAPHIC 5005
3 GRAPHIC g608161notacc1b.jpg GRAPHIC 1299
4 GRAPHIC g608161notacc2a.jpg GRAPHIC 3355
5 GRAPHIC g608161notacc2b.jpg GRAPHIC 1298
6 GRAPHIC g608161notacc3.jpg GRAPHIC 1470
7 GRAPHIC g608161notacc4.jpg GRAPHIC 1477
  Complete submission text file 0001193125-18-142673.txt   63750
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 18789004
SIC: 2834 Pharmaceutical Preparations